Sai Life Sciences IPO GMP: Price, Dates, Financials, and Subscription Details
Sai Life Sciences Ltd is all set to launch its IPO, generating significant buzz in the investment community. Investors are closely tracking the Sai Life Sciences IPO GMP (Grey Market Premium) and other key details to evaluate the offering’s potential.
This article provides all the essential information, including IPO dates, price band, lot size, financials, and company strengths.
Sai Life Sciences IPO Details:
The Sai Life Sciences IPO is a book-built issue worth ₹3,042.62 crores. It includes:
- Fresh Issue: 1.73 crore shares, aggregating to ₹950 crores
- Offer for Sale (OFS): 3.81 crore shares, aggregating to ₹2,092.62 crores
Here’s a summary of the IPO details:
| Details | Information |
|---|---|
| IPO Date | December 11, 2024 – December 13, 2024 |
| Listing Date | December 18, 2024 (Tentative) |
| Price Band | ₹522 to ₹549 per share |
| Lot Size | 27 Shares |
| Total Issue Size | ₹3,042.62 Cr (55,421,123 shares) |
| Listing At | BSE, NSE |
Sai Life Sciences Reservation Breakdown:
| Investor Category | Shares Offered |
|---|---|
| QIB (Qualified Institutional Buyers) | Not more than 50% of the Net Issue |
| Retail Investors | Not less than 35% |
| NII (HNI Investors) | Not less than 15% |
Sai Life Sciences IPO Timeline:
Here’s the tentative IPO timeline:
- IPO Open Date: December 11, 2024
- IPO Close Date: December 13, 2024
- Basis of Allotment: December 16, 2024
- Refunds Initiated: December 17, 2024
- Shares Credited to Demat: December 17, 2024
- Listing Date: December 18, 2024
Sai Life Sciences IPO Lot Size:
The minimum and maximum investments for retail and HNI investors are as follows:
| Investor Type | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 27 | ₹14,823 |
| Retail (Max) | 13 | 351 | ₹192,699 |
| sNII (Min) | 14 | 378 | ₹207,522 |
| bNII (Min) | 68 | 1,836 | ₹1,007,964 |
About Sai Life Sciences Ltd:
Incorporated in January 1999, Sai Life Sciences is a leading Contract Research and Development Manufacturing Organization (CRDMO) offering:
- Custom R&D and manufacturing solutions to global pharma and biotech companies.
- Integrated discovery services across biology, chemistry, and pharmacokinetics.
The company works with over 280 pharmaceutical clients, including 18 of the top 25 global pharma companies.
Company Financials
Sai Life Sciences has demonstrated robust financial growth:
| Period | Revenue | Profit After Tax | Net Worth |
|---|---|---|---|
| FY 2023-24 | ₹1,494.27 Cr | ₹82.81 Cr | ₹974.34 Cr |
| FY 2022-23 | ₹1,245.11 Cr | ₹9.99 Cr | ₹887.29 Cr |
Competitive Strengths of Sai Life Sciences
- Integrated CRDMO Platform: Complete value chain from discovery to manufacturing.
- Global Client Base: Serving top-tier pharma companies across the US, UK, Europe, and Japan.
- Strong Scientific Workforce: Over 2,300 scientists, including 302 PhDs and 1,475 Master’s degree holders.
Sai Life Sciences IPO GMP
The Grey Market Premium (GMP) is a strong indicator of investor sentiment ahead of the IPO listing. GMP is the premium amount at which shares are traded in the unofficial market before listing.
For more details on GMP and its significance, read our article on IPO GMP – Grey Market Premium.
How Sai Life Sciences IPO Stands Out
- Fresh Issue and OFS: A balanced approach with fresh capital infusion and an Offer for Sale (OFS). Learn more about IPO types in our detailed blog: OFS vs IPO Differences.
- Financial Growth: The company’s revenue growth and strong client base demonstrate its market potential.
Is Sai Life Sciences IPO Worth Investing?
The IPO offers significant potential due to the company’s strong financials, global presence, and niche expertise in CRDMO services. However, investors must evaluate their risk appetite and conduct thorough research before investing.
Additionally, for short-term opportunities, investors often explore IPO flipping. Learn more about this strategy in our article on IPO Flipping.
FAQs About Sai Life Sciences IPO
1. What are the Sai Life Sciences IPO dates?
The IPO opens on December 11, 2024, and closes on December 13, 2024.
2. What is the Sai Life Sciences IPO price band?
The price band is set at ₹522 to ₹549 per share.
3. How much should retail investors invest in Sai Life Sciences IPO?
The minimum investment for retail investors is ₹14,823 for a lot size of 27 shares.
4. What is Sai Life Sciences’ business focus?
Sai Life Sciences specializes in CRDMO services, offering discovery, development, and manufacturing solutions to global pharma companies.
5. When will the Sai Life Sciences IPO list on the stock exchanges?
The tentative listing date is December 18, 2024, on both BSE and NSE.
Stay informed and invest wisely with Tap Invest. For more educational content on IPOs and alternative investments, visit our blog at Tap Invest
